Skip to content
  • My Accountmy account
  • Search
FLCCC | Front Line COVID-19 Critical Care Alliance
  • Treatment
    Protocols

    • Protocols

      Read about strategies to prevent and treat conditions like COVID-19, insulin resistance, RSV, long COVID, and more.

      Learn More
      Prevention

      Boost your immune system, clear your body of spike protein, and learn the benefits of intermittent fasting.

      • EAT WELL
      • I-PREVENT Vaccine Injury
      • See all Prevention Protocols
      Treatment

      At-home and hospital treatment plans for COVID, insulin resistance, sepsis, RSV and flu.

      • I-CARE Early At Home Treatment
      • I-CARE RSV and Flu Treatment
      • See all Treatment Protocols
      Recovery

      Approaches to managing symptoms from long COVID and long Vax.

      • I-RECOVER Post Vaccine Treatment
      • I-RECOVER Long Covid
      • See all Recovery Protocols
  • Medical
    Evidence
    • Reviews & Monographs

      In-depth academic pieces presenting original research, analysis, and evidence on complex conditions.

      Cancer Care
    • Studies

      A comprehensive listing of all research, studies, authors and sources cited in each FLCCC prevention and treatment protocol for COVID-19

      Learn More
    • Lectures

      Watch FLCCC doctors speak at international medical conferences, professional seminars and symposiums.

      Learn More
    • Senate Testimony

      Watch Dr. Pierre Kory testify before the U.S. Senate regarding FLCCC protocols to treat COVID-19.

      Learn More
  • COVID
    Resources

    • Wondering where to begin?

      Let us help you find what you’re looking for. We know COVID-19 can be overwhelming; click below to learn more about the resources available to you on this website.

      get started
      Patient Resources
      • Find a Provider
      • Find a Pharmacy
      • Tools & Guides
      • Testimonials
      • Hospital Guide
      Practitioner Resources
      • Efficacy of Ivermectin
      • Informed Consent
      • Nurses for FLCCC
      • Join the Alliance
      • Education on Demand
  • Education &
    Events

    • About the education portal

      FLCCC’s goal is to educate healthcare providers and empower patients with the tools and resources they need to take control of their own health.

      Events

      Our twice-yearly conferences bring top experts from a variety of fields together to learn, share, and network with each other.

      • Learn More
      Education on Demand

      Stream video lectures, download slide presentations, and get exclusive access to key facts, data, and references from FLCCC educational programs.

      • My Content
      • Explore Courses
  • News &
    Webinars
    • Latest Updates

      Stay up-to-date with the latest news from our fast-moving field.

      View
    • Blog

      Subscribe to our blog to read our weekly news capsule and be the first to receive the latest announcements from FLCCC.

      Read Now
    • Weekly Webinars

      Sign up for our webinars, every Wednesday at 7pm ET, offering the latest information on therapeutics and treatments and answering audience questions.

      Learn More
    • FLCCC in the News

      Read media coverage of FLCCC from around the world.

      View
  • About
    FLCCC

    • About the FLCCC

      Learn about the history of FLCCC, our mission and vision, and how you can get involved.

      learn more
      • Our Physicians
      • Our Partners
      • Advocacy
      • FAQ
      • Terms and Conditions
      • Impact Reports
      • Annual Reports
      • Support Us
      • Shop our Store
      • Connect with Us
  • Donate
  • Treatment Protocols
  • Find a Provider
  • Find a Pharmacy
  • Medical Evidence
    • Cancer Care
    • Studies
    • Lectures
    • Senate Testimony
  • COVID Resources
    • Get Started
    • Tools & Guides
    • Ivermectin
    • Hospital Guide
    • Nurses for FLCCC
    • Join The Alliance
  • Education & Events
    • Educational Conference
    • Education on Demand
    • My Content
  • News & Webinars
    • Latest Updates
    • FLCCC Blog
    • Weekly Webinars
    • FLCCC in the News
  • About The FLCCC
  • FAQ
  • Connect with Us
  • Donate
  • Cart
FLCCC | Front Line COVID-19 Critical Care Alliance
  • Treatment Protocols
  • Find a Provider
  • Find a Pharmacy
  • Medical Evidence
    • Cancer Care
    • Studies
    • Lectures
    • Senate Testimony
  • COVID Resources
    • Get Started
    • Tools & Guides
    • Ivermectin
    • Hospital Guide
    • Nurses for FLCCC
    • Join The Alliance
  • Education & Events
    • Educational Conference
    • Education on Demand
    • My Content
  • News & Webinars
    • Latest Updates
    • FLCCC Blog
    • Weekly Webinars
    • FLCCC in the News
  • About The FLCCC
  • FAQ
  • Connect with Us
  • Donate
  • Cart
Donate

References

Categories

I-CARE Early Covid (187) I-CARE Flu and RSV (36) I-PREVENT (153) I-RECOVER Long Covid (111) I-RECOVER Post-Vaccine (320) MATH+ (171)

Tags

ACE2 protein (10) acute respiratory distress syndrome (13) Alopecia (7) Anti-inflammatory (8) Antidepressants (9) Ascorbic Acid (9) autoantibodies (10) autophagy (24) Calcifediol (6) Cancer (9) Corticosteroids (8) COVID-19 (255) COVID-19 Vaccines (8) Curcumin (8) Cytokines (10) Depression (10) Famotidine (14) flavonoids (5) Glucocorticoids (6) Hydroxychloroquine (12) Hyperbaric Oxygen Therapy (9) Inflammation (14) ivermectin (46) long COVID (21) Mast Cells (8) Melatonin (20) molnupiravir (5) N-Acetylcysteine (6) Non-Invasive Brain Stimulation (8) Omicron (7) Oxytocin (8) Pneumonia (8) quercetin (15) resveratrol (5) SARS-CoV-2 (72) SARS-CoV-2 mRNA Vaccines (7) Sepsis (15) spermidine (11) Spike Protein (10) Thrombosis (9) Tinnitus (12) Valproic Acid (5) Vitamin C (16) Vitamin D (9) Zinc (12)
  • Reference: Autoantibodies targeting GPCRs and RAS-related molecules associated with COVID-19 severity.

    Published On: March 9, 2022

    Authors: Cabral-Marques O, Halpert G, Schimke LF, Ostrinski Y, Vojdani A, Lattin MT PMID: 35264564 PMCID: PMC8907309 DOI: 10.1038/s41467-022-28905-5 Abstract COVID-19 shares the feature of autoantibody production with systemic autoimmune diseases. In order to understand the role of these immune globulins in the pathogenesis of the disease, it is important to explore the autoantibody spectra. [...]

    Categories: I-RECOVER Long Covid, I-RECOVER Post-Vaccine

    Tags: autoantibodies, COVID-19

  • Reference: Development of ACE2 autoantibodies after SARS-CoV-2 infection.

    Published On: September 3, 2021

    Authors: Arthur JM, Forrest JC, Boehme KW, Kennedy JL, Owens S, Liu J PMID: 34478478 PMCID: PMC8415618 DOI: 10.1371/journal.pone.0257016 Abstract Background: Activation of the immune system is implicated in the Post-Acute Sequelae after SARS-CoV-2 infection (PASC) but the mechanisms remain unknown. Angiotensin-converting enzyme 2 (ACE2) cleaves angiotensin II (Ang II) resulting in decreased activation of [...]

    Categories: I-RECOVER Long Covid, I-RECOVER Post-Vaccine

    Tags: ACE2 protein, autoantibodies, COVID-19

  • Reference: Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-Covid-19 symptoms.

    Published On: April 16, 2021

    Authors: Wallukat G, Hohberger B, Wenzel K, Furst J, Wallukat A PMID: 33880442 PMCID: PMC8049853 DOI: 10.1016/j.jtauto.2021.100100 Abstract Impairment of health after overcoming the acute phase of COVID-19 is being observed more and more frequently. Here different symptoms of neurological and/or cardiological origin have been reported. With symptoms, which are very similar to the ones [...]

    Categories: I-RECOVER Long Covid

    Tags: autoantibodies, long COVID, symptoms

  • Reference: Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-Covid-19 symptoms.

    Published On: April 16, 2021

    Authors: Wallukat G, Hohberger B, Wenzel K, Furst J, Wallukat A PMID: 33880442 PMCID: PMC8049853 DOI: 10.1016/j.jtauto.2021.100100 Abstract Impairment of health after overcoming the acute phase of COVID-19 is being observed more and more frequently. Here different symptoms of neurological and/or cardiological origin have been reported. With symptoms, which are very similar to the ones [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: autoantibodies, long COVID

  • Reference: Diverse functional autoantibodies in patients with COVID-19.

    Published On: February 1, 2021

    Authors: Wang EY, Mao T, Klein J, Dai Y, Huck JD, Jaycox JR PMID: 33330894 PMCID: PMC7743105 DOI: 10.1101/2020.12.10.20247205 Abstract COVID-19 manifests with a wide spectrum of clinical phenotypes that are characterized by exaggerated and misdirected host immune responses1-8. While pathological innate immune activation is well documented in severe disease1, the impact of autoantibodies on [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: autoantibodies, COVID-19

  • Reference: COVID-19 and immunological dysregulation: can autoantibodies be useful?

    Published On: January 20, 2021

    Authors: Pascolini S, Vannini A, Deleonardi G, Ciordinik M, Sensoli A PMID: 32989903 PMCID: PMC7536986 DOI: 10.1111/cts.12908 Abstract Coronavirus disease 2019 (COVID-19) is often associated with interstitial pneumonia. However, there is insufficient knowledge on the presence of autoimmune serological markers in patients with COVID-19. We analyzed the presence and role of autoantibodies in patients with [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: autoantibodies, COVID-19

  • Reference: High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms.

    Published On: December 24, 2020

    Authors: Franke C, Ferse C, Kreye J, Rocco A, Hosp J PMID: 33359380 PMCID: PMC7834471 DOI: 10.1016/j.bbi.2020.12.022 Abstract Background: COVID-19 intensive care patients can present with neurological syndromes, usually in the absence of SARS-CoV-2 in cerebrospinal fluid (CSF). The recent finding of some virus-neutralizing antibodies cross-reacting with brain tissue suggests the possible involvement of specific [...]

    Categories: I-RECOVER Long Covid

    Tags: autoantibodies, COVID-19

  • Reference: Prothrombotic autoantibodies in the serum from patients hospitalized with COVID-19.

    Published On: November 2, 2020

    Authors: Zuo Y, Estes SK, Ali RA, Gandhi AA, Shi H PMID: 33139519 PMCID: PMC7724273 DOI: 10.1126/scitranslmed.abd3876 Abstract Patients with COVID-19 are at high risk for thrombotic arterial and venous occlusions. Lung histopathology often reveals fibrin-based blockages in the small blood vessels of patients who succumb to the disease. Antiphospholipid syndrome is an acquired and [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: autoantibodies, COVID-19

  • Reference: Immunoserologic detection and diagnostic relevance of cross-reactive autoantibodies in Coronavirus disease 2019 patients.

    Published On: October 1, 2020

    Authors: Schiaffino MT, Di Natale M, Garcia-Martinez E, Navarro J, Munoz-Blanco JL, Demelo-Rodriguez P PMID: 32738141 PMCID: PMC7454719 DOI: 10.1093/infdis/jiaa485 Abstract Background: During the coronavirus disease 2019 (COVID-19) pandemic, we detected a new immunofluorescence (IF) pattern in serum autoantibody (autoAb) screening of laboratory-confirmed COVID-19 patients. Methods: The IF pattern was composed of liver and gastric [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: autoantibodies, COVID-19

  • Reference: Cryptogenic small-fiber neuropathies: Serum autoantibody binding to trisulfated heparin disaccharide and fibroblast growth factor receptor-3.

    Published On: November 6, 2019

    Authors: Levine TD, Kafaie J, Zeidman LA, Saperstein DS, Bland RJ PMID: 31650561 DOI: 10.1002/mus.26748 Abstract Introduction: Causes of small-fiber peripheral neuropathies (SFN) are often undefined. In this study we investigated associations of serum autoantibodies, immunoglobulin G (IgG) vs fibroblast growth factor receptor-3 (FGFR-3), and immunoglobulin M (IgM) vs trisulfated heparan disaccharide (TS-HDS) in cryptogenic [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: autoantibodies, Small-Fiber Neuropathies

FLCCC Logo with white letters
Support Us

We are a 100% donor-supported 501(c)(3) non-profit organization. Our work would not be possible without you! Help us expand our reach and share life-saving research.

Give Now
shop
Contact Us
Mailing Address

FLCCC Alliance
2001 L St. NW Suite 500
Washington, DC 20036

Media

[email protected]

Clinical Support

[email protected]

General

[email protected]

Shortcuts
  • About the FLCCC

  • Protocols

  • Providers

  • Physicians

  • Testimonials